000 01485 a2200421 4500
005 20250517095557.0
264 0 _c20180402
008 201804s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/srep26742
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarathe, Bindumadhav M
245 0 0 _aCombinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice.
_h[electronic resource]
260 _bScientific reports
_c05 2016
300 _a26742 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAmides
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aDogs
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aInfluenza A Virus, H5N1 Subtype
650 0 4 _aMadin Darby Canine Kidney Cells
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aOrthomyxoviridae Infections
_xdrug therapy
650 0 4 _aOseltamivir
_xpharmacology
650 0 4 _aPyrazines
_xpharmacology
700 1 _aWong, Sook-San
700 1 _aVogel, Peter
700 1 _aGarcia-Alcalde, Fernando
700 1 _aWebster, Robert G
700 1 _aWebby, Richard J
700 1 _aNajera, Isabel
700 1 _aGovorkova, Elena A
773 0 _tScientific reports
_gvol. 6
_gp. 26742
856 4 0 _uhttps://doi.org/10.1038/srep26742
_zAvailable from publisher's website
999 _c26055891
_d26055891